Cano Health Inc. (NYSE:CANO) finished Thursday with an addition of $0.16 to close at $1.23, an upside of 14.95 percent. An average of 7,082,040 shares of common stock have been traded in the last five days. There was a gain of $0.0400 in the past week, and it reached a new high 4 times over the past 12 months. The last 20 days have seen an average of 9,149,025 shares traded, while the 50-day average volume stands at 12,335,486.
CANO stock has decreased by -28.07% in the last month. The company shares reached their 1-month lowest point of $0.9801 on 12/27/22. With the stock rallying to its 52-week high on 10/07/22, shares of the company touched a low of $0.98 and a high of $9.75 in 52 weeks. It has reached a new high 3 times so far this year and lost -86.20% or -$7.6800 in price. In spite of this, the price is down -87.38% from the 52-week high.
Cano Health Inc. (CANO) has a trailing price-to-sales (P/S) ratio at 0.25, the price-to-book (PB) ratio at 0.70.
Further, the company has a long term debt to equity ratio of 2.26 and a total debt to equity ratio of 2.28 for the quarter ending June 29. Its gross profit as reported stood at $1.74 billion compared to revenue of $1.61 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Cano Health Inc.’s return on assets was -3.30%.
For the three-month period that ended June 29, Cano Health Inc. had $914.39 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$54.23 million in the quarter, while revenues of -$5.33 million were grew 73.0%. The analyst consensus anticipated Cano Health Inc.’s latest quarter earnings to come in at -$0.05 per share, but it turned out to be -$0.03, a 40.00% surprise. For the quarter, EBITDA amounted to -$4.93 million. Shareholders own equity worth $494.48 million.
From a technical analysis perspective, let’s take a brief look at Cano Health Inc. (CANO) price momentum. RSI 9-day as of the close on 29 December was 43.39%, suggesting the stock is Neutral, with historical volatility in this time frame at 109.88%.
As of today, CANO’s price is $1.0960 +3.36% or $0.0400 from its 5-day moving average. CANO is currently trading -35.26% lower than its 20-day SMA and -79.70% lower than its 100-day SMA. However, the stock’s current price level is -71.98% below the SMA50 and -79.60% below the SMA200.
The stochastic %K and %D were 23.45% and 11.48%, respectively, and the average true range (ATR) was 0.1572. With the 14-day stochastic at 48.07% and the average true range at 0.1945, the RSI (14) stands at 35.50%. The stock has reached -0.0267 on the 9-day MACD Oscillator while the 14-day reading was at -0.0862.
What is CANO’s price target for the next 12 months?
Analysts predict a range of price targets between $1.20 and $12.00, with a median target of $5.00. Taking a look at these predictions, the average price target given by analysts for Cano Health Inc. (CANO) stock is $5.53.